1. Home
  2. PCVX vs MTZ Comparison

PCVX vs MTZ Comparison

Compare PCVX & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • MTZ
  • Stock Information
  • Founded
  • PCVX 2013
  • MTZ 1929
  • Country
  • PCVX United States
  • MTZ United States
  • Employees
  • PCVX N/A
  • MTZ N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • MTZ Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • PCVX Health Care
  • MTZ Industrials
  • Exchange
  • PCVX Nasdaq
  • MTZ Nasdaq
  • Market Cap
  • PCVX 4.5B
  • MTZ 8.8B
  • IPO Year
  • PCVX 2020
  • MTZ N/A
  • Fundamental
  • Price
  • PCVX $31.16
  • MTZ $148.22
  • Analyst Decision
  • PCVX Strong Buy
  • MTZ Strong Buy
  • Analyst Count
  • PCVX 10
  • MTZ 17
  • Target Price
  • PCVX $136.50
  • MTZ $157.81
  • AVG Volume (30 Days)
  • PCVX 2.2M
  • MTZ 861.9K
  • Earning Date
  • PCVX 05-07-2025
  • MTZ 05-01-2025
  • Dividend Yield
  • PCVX N/A
  • MTZ N/A
  • EPS Growth
  • PCVX N/A
  • MTZ N/A
  • EPS
  • PCVX N/A
  • MTZ 2.70
  • Revenue
  • PCVX N/A
  • MTZ $12,464,333,000.00
  • Revenue This Year
  • PCVX N/A
  • MTZ $10.26
  • Revenue Next Year
  • PCVX N/A
  • MTZ $8.41
  • P/E Ratio
  • PCVX N/A
  • MTZ $54.62
  • Revenue Growth
  • PCVX N/A
  • MTZ 3.03
  • 52 Week Low
  • PCVX $27.66
  • MTZ $89.96
  • 52 Week High
  • PCVX $121.06
  • MTZ $166.95
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 36.73
  • MTZ 73.74
  • Support Level
  • PCVX $28.09
  • MTZ $121.82
  • Resistance Level
  • PCVX $33.75
  • MTZ $150.73
  • Average True Range (ATR)
  • PCVX 2.54
  • MTZ 5.11
  • MACD
  • PCVX 1.12
  • MTZ 2.84
  • Stochastic Oscillator
  • PCVX 35.61
  • MTZ 93.47

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.

Share on Social Networks: